Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-15, Stock:LLY, The news for the past five days is as follows:
2021-12-08: NEWS1: Eli Lilly's Pipeline Strength Paints a Promising Outlook.NEWS2: UPDATE 2-China approves Brii Biosciences antibody COVID treatment.
2021-12-09: NEWS1: AstraZeneca (AZN) Gets FDA Nod for COVID Prevention Drug.NEWS2: New Lilly Study Reveals Underappreciation of Bowel Urgency as a Symptom of Ulcerative Colitis and Highlights Communication Gap Between Healthcare Providers and Patients.
2021-12-10: NEWS1: UPDATE 2-Drugmakers aim big price hikes at U.S. patients, congressional report finds.NEWS2: Eli Lilly Pens $1.5B Pact With Regor For Metabolic Disease Therapies.NEWS3: Drugmakers aim big price hikes at U.S. patients, congressional report finds.NEWS4: Drugmakers aim big price hikes at U.S. patients -congressional report.NEWS5: Pharma Stock Roundup: PFE Booster Works on Omicron, AZN COVID Cocktail Gets FDA Nod.NEWS6: Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders.
2021-12-13: NEWS1: Eli Lilly (LLY) Gains As Market Dips: What You Should Know.NEWS2: Why Foghorn Therapeutics Blasted 55% Higher Today.NEWS3: Calamos Growth and Income Portfolio Buys Abbott Laboratories, Huntington Bancshares Inc, Eli ....NEWS4: Eli Lilly hikes quarterly dividend 15%.NEWS5: T. Rowe Price Exchange-Traded Funds, Inc. Buys Microsoft Corp, Amazon. ....NEWS6: Lilly Announces 15 Percent Dividend Increase, First-Quarter 2022 Dividend.NEWS7: Foghorn Forms Oncology Partnership With Eli Lilly. The Stock Is Soaring..NEWS8: Lilly (LLY) Inks Metabolic Disorders Therapy Development Deal.NEWS9: Foghorn Therapeutics Stock Surges After $1.5B Cancer Pact With Eli Lilly.NEWS10: Foghorn Therapeutics shares soar 26% premarket on news of cancer collaboration with Eli Lilly.NEWS11: Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control® Platform.NEWS12: Foghorn Therapeutics Jumps on Eli Lilly Collaboration.
2021-12-14: NEWS1: Mirikizumab Demonstrates Superiority over Placebo in Phase 3 Maintenance Study in Ulcerative Colitis, Supporting Regulatory Submissions in 2022.NEWS2: Eli Lilly Strikes Deal With Chinese Company on New Drugs for Diabetes.NEWS3: Who Has What? Omicron Raises Stakes for Quick Covid Sequencing.NEWS4: PFE vs. LLY: Which Stock Should Value Investors Buy Now?.NEWS5: Foghorn (FHTX) Surges on Oncology Collaboration With Lilly.NEWS6: Company News for Dec 14, 2021.NEWS7: Eli Lilly and Foghorn Partner Up. Foghorn Stock Soared..

Answer: Rise